MedTrace Logo

Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

NCT05563883 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000000

Last updated 2022-10-03

No results posted yet for this study

Summary

Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known.

The objective of this study is to use a very large French nationwide cohort to adress thèses questions.

Conditions

Interventions

OTHER

event occurence

occurence of an event of interest: (AF, cancer, thromboembolism, bleeding, mortality...

Sponsors & Collaborators

  • University Hospital, Tours

    collaborator OTHER

  • University Hospital, Caen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2030-01-31
Completion
2030-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05563883 on ClinicalTrials.gov